Global WholeHealth Partners Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GWHP research report →
Price Chart
About the company
Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests. These diagnostic tools are designed for wide accessibility, catering to both over-the-counter consumer purchases and professional point-of-care settings such as hospitals, physicians' offices, and various medical clinics.
- CEO
- Edgar B. Gonzalez
- IPO
- 2015
- HQ
- San Clemente, CA, US
Get TickerSpark's AI analysis on GWHP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.31K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.18
- P/B
- -0.00
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
- Gross Margin
- -1518.64%
- Op Margin
- -56759.32%
- Net Margin
- -69898.31%
- ROE
- 618.63%
- ROIC
- 477.11%
Latest fiscal year · YoY change
- Revenue
- $7.38K-81.7%
- Gross Profit
- $-112,000+30.4%
- Op Income
- $-4,186,000
- Net Income
- $-5,155,000+42.9%
- EPS
- $-0.05+60.8%
- OCF Growth
- -206.2%
- FCF Growth
- -204.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -11.47
- RSI (14)
- 88
- Avg Volume
- 6
No earnings-call transcripts are available for GWHP yet.
- Free Float
- 90.6%
- Shares Outstanding
- 131.29M
- Float Shares
- 118.94M
Our GWHP coverage
Recent articles, reports, and earnings notes.
No research on GWHP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GWHP report →Head to Head Comparison: Fonar (NASDAQ:FONR) and Global Wholehealth Partners (OTCMKTS:GWHP)
defenseworld.net · Dec 16
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
globenewswire.com · Oct 14
Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace
globenewswire.com · Oct 12
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
globenewswire.com · Sep 29
FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp (OTC: GWHP) as US Anticipates Considerable Uptick in Vaccination Rates, as Stated in 8K Filing 06/15/21
globenewswire.com · Aug 24
Global WholeHealth Partners Corp. (OTC:GWHP) Gains Approval in a Deal to Sell Through Ebay's $100 Billion Online Marketplace as Stated in 8K Filing 08/05/21
globenewswire.com · Aug 10
Global WholeHealth Partners Corp.'s (OTC: GWHP) Antibody IgG/IgM and Antigen Tests That They Offer Are Capable of Detecting the DELTA B.1.617.2, United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) of COVID 19 SARS 2
globenewswire.com · Jul 26
Global WholeHealth Partners, Corp. (OTC: GWHP) Confirms They Offer Antibody and Antigen Test Kits That Detect Fast Spreading Mutated COVID-19 Strains, DELTA (B.1.617.2), (UK (B.1.1.7), S. Africa (B.
globenewswire.com · Jul 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.